TRIANGLE RESIDENTIAL OPTIONS FOR SUBSTANCE ABUSERS Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • TRIANGLE RESIDENTIAL OPTIONS FOR SUBSTANCE ABUSERS's estimated annual revenue is currently $4.9M per year.(i)
  • TRIANGLE RESIDENTIAL OPTIONS FOR SUBSTANCE ABUSERS's estimated revenue per employee is $189,000

Employee Data

  • TRIANGLE RESIDENTIAL OPTIONS FOR SUBSTANCE ABUSERS has 26 Employees.(i)
  • TRIANGLE RESIDENTIAL OPTIONS FOR SUBSTANCE ABUSERS grew their employee count by -4% last year.

TRIANGLE RESIDENTIAL OPTIONS FOR SUBSTANCE ABUSERS's People

NameTitleEmail/Phone
1
FounderReveal Email/Phone
2
Chief Program OfficerReveal Email/Phone
3
Chief Strategy OfficerReveal Email/Phone
4
Chief Development Officer (CDO)Reveal Email/Phone
5
Director Men's ProgramReveal Email/Phone
6
Director ComplianceReveal Email/Phone
7
Director Business OperationsReveal Email/Phone
8
Medical Special Projects ManagerReveal Email/Phone
9
Residential House ManagerReveal Email/Phone
10
Gifts-in-Kind Department ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$76.6M2580%N/AN/A
#2
$109.4M324-1%N/AN/A
#3
$7.8M36-3%N/AN/A
#4
$14.3M59-3%N/AN/A
#5
$27.3M10117%N/AN/A
#6
$17M70-7%N/AN/A
#7
$1.6M10-68%N/AN/A
#8
$421.5M1115N/AN/AN/A
#9
$29.7M110-21%N/AN/A
#10
$58.2M1968%N/AN/A
Add Company

What Is TRIANGLE RESIDENTIAL OPTIONS FOR SUBSTANCE ABUSERS?

TROSA is a comprehensive, long-term, residential substance abuse recovery program located in Durham, North Carolina. The TROSA philosophy is based on principles of self-help and individual empowerment. Key elements of the program include vocational training, education, communication, peer counseling/mentoring, leadership training and aftercare.

keywords:N/A

N/A

Total Funding

26

Number of Employees

$4.9M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.5M260%N/A
#2
$3.7M26-28%N/A
#3
$1.8M264%N/A
#4
N/A2673%N/A
#5
$2.5M26-38%N/A